He is heading a research group focusing on translational research in the area of cancer immunology & immunotherapy at the Department of Biomedicine. In addition, he is conducting clinical trials as well as supervising clinical research.
Prof. Zippelius is author of > 150 high-impact publications and inventor of several patents in the field of cancer immunology, and during his career has received numerous fellowships and awards, including competitive DFG/Emmy-Noether fellowship, SNF Excellenza and Dora Seif Cancer Award. Prof. Zippelius is on a number of international review and advisory boards, including review functions for leading journals such as NEJM, Cell, Nature Cancer and Nature Medicine, and for national and international funding institutes. Prof. Zippelius is Section Editor at JITC and also active in many national and international professional societies.